David M. DeMedio
Plus aucun poste en cours
Historique de carrière de David M. DeMedio
Anciens postes connus de David M. DeMedio
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CANTALOUPE, INC. | Directeur Financier/CFO | 01/03/1999 | 31/08/2015 |
| Corporate Officer/Principal | 31/08/2015 | 14/10/2015 | |
Gammacan International, Inc.
 Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Directeur/Membre du Conseil | 01/10/2007 | 17/09/2008 |
Formation de David M. DeMedio
| Shippensburg University of Pennsylvania | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Israël | 2 |
Opérationnelle
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sectorielle
| Finance | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CANTALOUPE, INC. | Finance |
| Entreprise privées | 1 |
|---|---|
Gammacan International, Inc.
Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Health Technology |
- Bourse
- Insiders
- David M. DeMedio
- Expérience
